{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:53:04Z","timestamp":1788403984049,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.pscychresns.2017.05.009","type":"journal-article","created":{"date-parts":[[2017,5,20]],"date-time":"2017-05-20T10:47:26Z","timestamp":1495277246000},"page":"73-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study"],"prefix":"10.1016","volume":"266","author":[{"given":"Sanna","family":"Huhtaniska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas","family":"Heikka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani S.","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Lehtiniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Tohka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 V.","family":"Manj\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierrick","family":"Coup\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lassi","family":"Bj\u00f6rnholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Koponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Veijola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Isohanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa","family":"Kiviniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham K.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouko","family":"Miettunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pscychresns.2017.05.009_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1176\/appi.ajp.2013.12050674","article-title":"Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study","volume":"170","author":"Andreasen","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00406-016-0711-8","article-title":"Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo","volume":"267","author":"Baandrup","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","article-title":"Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis","volume":"19","author":"Barker","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S1355617705050332","article-title":"An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use","volume":"11","author":"Barker","year":"2005","journal-title":"J. Int Neuropsychol. Soc."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/archpsyc.1992.01820120054008","article-title":"Striatal metabolic rate and clinical response to neuroleptics in schizophrenia","volume":"49","author":"Buchsbaum","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004714-200002000-00002","article-title":"Long-term benzodiazepine therapy does not result in brain abnormalities","volume":"20","author":"Busto","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib9","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.pnpbp.2008.09.020","article-title":"Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine","volume":"32","author":"Crespo-Facorro","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neulet.2015.12.048","article-title":"Chronic benzodiazepine treatment decreases spine density in cortical pyramidal neurons","volume":"613","author":"Curto","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1192\/bjp.166.5.650","article-title":"A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients","volume":"166","author":"Day","year":"1995","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib12","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/sj.npp.1300710","article-title":"The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys","volume":"30","author":"Dorph-Petersen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.31887\/DCNS.2004.6.2\/rduman","article-title":"Neural plasticity: consequences of stress and actions of antidepressant treatment","volume":"6","author":"Duman","year":"2004","journal-title":"Dialog. Clin. Neurosci."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib14","first-page":"438","article-title":"Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review","volume":"20","author":"Ebdrup","year":"2013","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib15","unstructured":"First, M., Spitzer, R., Gibbon, M., Williams, J., 2002. Structured Clinical Interview for DSM-IV-TR Axis I Disorders. Research Version, Patient Edition With Psychotic Screen (SCID-I\/P W\/PSYSCREEN). BiometricsResearch, New York State Psychiatric Institute, New York."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4088\/JCP.15m10271","article-title":"Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study. Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study.","volume":"77","author":"Fontanella","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib17","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.neubiorev.2013.06.001","article-title":"Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies","volume":"37","author":"Fusar-Poli","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.schres.2015.06.016","article-title":"Longitudinal regional brain volume loss in schizophrenia: relationship to antipsychotic medication and change in social function","volume":"168","author":"Guo","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2574","article-title":"Long-term antipsychotic use and brain changes in schizophrenia \u2013 a systematic review and meta-analysis","volume":"32","author":"Huhtaniska","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1046\/j.1471-4159.2003.02216.x","article-title":"Diazepam-induced adaptive plasticity revealed by alpha1 GABAA receptor-specific expression profiling","volume":"88","author":"Huopaniemi","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.schres.2014.06.035","article-title":"Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia \u2013 an observational 9-year follow-up study","volume":"158","author":"Husa","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00789044","article-title":"A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia","volume":"32","author":"Isohanni","year":"1997","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(76)90890-4","article-title":"Cerebral ventricular size and cognitive impairment in chronic schizophrenia","volume":"2","author":"Johnstone","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib25","doi-asserted-by":"crossref","first-page":"2612276","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib26","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.neuron.2011.06.034","article-title":"Loss of sensory input causes rapid structural changes of inhibitory neurons in adult mouse visual cortex","volume":"71","author":"Keck","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pnpbp.2011.11.008","article-title":"Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic","volume":"36","author":"Kitajima","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.biopsych.2007.08.018","article-title":"Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys","volume":"63","author":"Konopaske","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib29","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/schbul\/sbt142","article-title":"Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders","volume":"40","author":"Koutsouleris","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns \u2013 a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S0033291700003214","article-title":"Computerized axial brain tomography in long-term benzodiazepine users","volume":"14","author":"Lader","year":"1984","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib32","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1176\/ajp.161.10.1829","article-title":"Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia","volume":"161","author":"Lang","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuroimage.2012.12.055","article-title":"The hypnotic zolpidem increases the synchrony of BOLD signal fluctuations in widespread brain networks during a resting paradigm","volume":"70","author":"Licata","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib34","doi-asserted-by":"crossref","first-page":"e84806","DOI":"10.1371\/journal.pone.0084806","article-title":"Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment","volume":"8","author":"Licata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"Lieberman","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0","article-title":"Neurotrophins and hippocampal synaptic transmission and plasticity","volume":"58","author":"Lu","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fpsyt.2012.00096","article-title":"Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness","volume":"3","author":"Mamah","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fninf.2016.00030","article-title":"volBrain: an online MRI brain volumetry system","volume":"10","author":"Manj\u00f3n","year":"2016","journal-title":"Front. Neuroinform."},{"issue":"7994","key":"10.1016\/j.pscychresns.2017.05.009_bib39","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(76)90984-3","article-title":"Cerebral atrophy and cognitive impairment in chronic schizophrenia","volume":"2","author":"Marsden","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00127-003-0638-z","article-title":"Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort","volume":"38","author":"Moilanen","year":"2003","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib41","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.eurpsy.2015.02.009","article-title":"Brain morphometry of individuals with schizophrenia with and without antipsychotic medication \u2013 the Northern Finland Birth Cohort 1966 Study","volume":"30","author":"Moilanen","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.schres.2005.07.031","article-title":"Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia","volume":"80","author":"Molina","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-1781(93)90037-H","article-title":"Computed axial brain tomograms in long-term benzodiazepine users","volume":"48","author":"Moodley","year":"1993","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/pds.2166","article-title":"Prescription patterns of patients diagnosed with schizophrenia in mental hospitals in Tashkent\/Uzbekistan and in four German cities","volume":"21","author":"Mundt","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.psychres.2015.11.013","article-title":"Use of psychiatric medications in schizophrenia and other psychoses in a general population sample","volume":"235","author":"Nyk\u00e4nen","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1017\/S0033291700026003","article-title":"Computerized axial tomographic studies following long-term use of benzodiazepines","volume":"17","author":"Perera","year":"1987","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0925-4927(01)00072-5","article-title":"A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration","volume":"106","author":"Puri","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib48","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.neubiorev.2012.07.012","article-title":"Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication","volume":"36","author":"Radua","year":"2012","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.yebeh.2015.03.001","article-title":"Use of antiepileptic or benzodiazepine medication and suicidal ideation \u2013 the Northern Finland Birth Cohort 1966","volume":"46","author":"Rissanen","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib50","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/1570159X13666150429002536","article-title":"Brain structural effects of antipsychotic treatment in schizophrenia: a systematic review","volume":"13","author":"Roiz-Santia\u00f1ez","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2012.07.014","article-title":"Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine","volume":"141","author":"Roiz-Santi\u00e1\u00f1ez","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1440-1819.2001.00783.x","article-title":"Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study","volume":"55","author":"Saijo","year":"2001","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0893-133X(00)00172-X","article-title":"The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics","volume":"24","author":"Scheepers","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib54","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1017\/S0033291700000660","article-title":"Enlargement of cerebrospinal fluid spaces in long-term benzodiazepine abusers","volume":"17","author":"Schmauss","year":"1987","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib55","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1176\/appi.ajp.2015.15070922","article-title":"Accelerated brain aging in schizophrenia: a longitudinal pattern recognition study","volume":"173","author":"Schnack","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib56","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.neubiorev.2011.12.015","article-title":"Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia","volume":"36","author":"Shepherd","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib57","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1248\/bpb.b12-00009","article-title":"Sertindole, a potent antagonist at dopaminen D2 receptors, induces autophagy by increasing reactive oxygen species in SH-SY5Y neuroblastoma cells","volume":"35","author":"Shin","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib58","unstructured":"Spitzer, L., Williams, J.B.W., Gibbon, M., First, M.B., 1989. Structured Clinical Interview for DSM-III-R \u2013 Patient Edition (SCID-P, 9\/1\/89 Version). Biometrics Research Department, New York State Psychiatric Institute, New York."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pscychresns.2011.11.008","article-title":"Longitudinal MRI study of the pituitary volume in chronic schizophrenia: a preliminary report","volume":"202","author":"Takahashi","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.schres.2009.12.006","article-title":"A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia","volume":"119","author":"Takahashi","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.schres.2008.12.029","article-title":"Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia","volume":"108","author":"Takahashi","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib62","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.pnpbp.2011.07.009","article-title":"A follow-up MRI study of the fusiform gyrus and middle and inferior temporal gyri in schizophrenia spectrum","volume":"35","author":"Takahashi","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pnpbp.2010.10.023","article-title":"Longitudinal volume changes of the pituitary gland in patients with schizotypal disorder and first-episode schizophrenia","volume":"35","author":"Takahashi","year":"2011","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib64","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neuroscience.2007.09.014","article-title":"Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats","volume":"150","author":"Terry","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib65","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.neuroscience.2007.03.003","article-title":"Oral haloperidol or risperidone treatment in rats: temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance","volume":"146","author":"Terry","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib66","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/jpet.106.106047","article-title":"Time-dependent cognitive deficits associated with first and second generation antipsychotics: cholinergic dysregulation as a potential mechanism","volume":"320","author":"Terry","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib67","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.neuroscience.2008.08.030","article-title":"Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats","volume":"156","author":"Terry","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib68","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.2015.15050618","article-title":"Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study","volume":"173","author":"Tiihonen","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib69","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/1471-244X-13-342","article-title":"Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis","volume":"13","author":"Torres","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-0327(87)90011-5","article-title":"Cerebral ventricular size in panic disorder","volume":"12","author":"Uhde","year":"1987","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.pscychresns.2017.05.009_bib71","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hup.1209","article-title":"Concomitant medication of psychoses in a lifetime perspective","volume":"26","author":"Vares","year":"2011","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"7","key":"10.1016\/j.pscychresns.2017.05.009_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101689","article-title":"Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication","volume":"18:9","author":"Veijola","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2013.09.012","article-title":"Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs-linking magnetic resonance imaging findings to cellular pathology","volume":"75","author":"Vernon","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib74","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.biopsych.2010.11.010","article-title":"Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation","volume":"69","author":"Vernon","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib75","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.biopsych.2015.02.008","article-title":"The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies","volume":"78","author":"Vita","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib76","series-title":"The Pharmacoepidemiology of Psychiatric Medications. Textbook in Psychiatric Epidemiology","first-page":"155","author":"Wang","year":"2011"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib77","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/0004867412450471","article-title":"Medication for psychosis \u2013 consumption and consequences: the second Australian national survey of psychosis","volume":"46","author":"Waterreus","year":"2012","journal-title":"Aust. N.Z. J. Psychiatry"},{"key":"10.1016\/j.pscychresns.2017.05.009_bib78","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology, 2010. Guidelines for ATC classification and DDD assignment 2011. Norwegian Institute of Public Health, Oslo."}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492716303791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492716303791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T20:21:10Z","timestamp":1656879670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492716303791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":78,"alternative-id":["S0925492716303791"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2017.05.009","relation":{},"ISSN":["0925-4927"],"issn-type":[{"value":"0925-4927","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research: Neuroimaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pscychresns.2017.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}